Precision Medicine Group Executive and Leadership Team

Margaret Keegan, the Chief Executive Officer at Precision Medicine Group, directs the overarching corporate strategy and operational execution. Keegan's leadership ensures the company's integrated team of experts effectively addresses the evolving challenges faced by pharmaceutical and life-sciences clients. This involves guiding the development and commercialization services that Precision Medicine Group provides, focusing on leveraging advanced lab sciences, translational informatics, regulatory affairs, and payer insights. Keegan's strategic vision drives the company's mission to conquer product development hurdles and achieve successful commercialization for its partners. The Chief Executive Officer's role is central to maintaining the company's position as a leader in its field, fostering an environment of innovation and client-centric solutions. Margaret Keegan's oversight ensures seamless collaboration across diverse expert functions, maximizing impact for clients.

Mark Clein, the Co-Founder & Chief Executive Officer at Precision Medicine Group, spearheads the company's strategic direction and foundational growth initiatives. Clein's dual role as co-founder imbues the organization with a deep understanding of its origins and long-term vision, guiding the integrated team of experts. This leadership ensures the effective delivery of development and commercialization services to pharmaceutical and life-sciences companies, addressing complex product lifecycle challenges. Clein's focus encompasses leveraging advanced lab sciences, translational informatics, regulatory affairs, and payer insights to drive client success. The Chief Executive Officer's strategic oversight is critical in navigating a rapidly evolving market environment. Mark Clein's influence is pivotal in shaping the company's collaborative approach and its commitment to conquering product development and commercialization obstacles for its partners.

Marcus Brown, the Vice President, Chief of Staff To the Chief Executive Officer at Precision Medicine Group, provides strategic support and operational coordination directly to the Chief Executive Officer. Brown's role is pivotal in ensuring the efficient execution of corporate initiatives and facilitating communication across key departments. This involves aligning operational efforts with the company's strategic goals, particularly in supporting pharmaceutical and life-sciences clients with development and commercialization services. The Vice President, Chief of Staff To the Chief Executive Officer's responsibilities include streamlining processes and enhancing the effectiveness of leadership directives. Marcus Brown's contribution is essential for driving strategic alignment and operational excellence throughout the organization. Brown ensures that the CEO's vision is translated into actionable plans.

Karl Deonanan, the Chief Financial Officer at Precision Medicine Group, manages the company's financial health and strategic fiscal planning. Deonanan's responsibilities include overseeing all financial operations, ensuring robust fiscal management to support the company's growth and service delivery to pharmaceutical and life-sciences clients. This involves guiding financial strategies that align with the complex demands of product development and commercialization services. The Chief Financial Officer's role is integral to maintaining the financial stability required for innovation in advanced lab sciences, translational informatics, and regulatory affairs. Karl Deonanan's expertise ensures that financial resources are optimally allocated to drive client success and support the company's evolving market position. Deonanan's leadership provides critical financial insights that inform strategic decision-making across the organization.

Michael Winston, the Translational Sciences Chief Operating Officer & Chief Financial Officer at Precision Medicine Group, directs critical operational functions and financial oversight within the translational sciences division. Winston's dual role ensures the seamless execution of development and commercialization services, particularly focusing on the scientific and financial aspects of bringing new therapies to market. This leadership integrates advanced lab sciences and translational informatics with sound financial management to address complex client challenges. The Chief Operating Officer & Chief Financial Officer's purview is essential for optimizing resource allocation and operational efficiency in a highly specialized field. Michael Winston's strategic financial acumen supports the company's ability to provide comprehensive solutions, from early-stage development through commercialization. Winston's operational leadership drives the effective implementation of scientific strategies.

Wendy Shusko, the Chief Financial Officer, Precision AQ at Precision Medicine Group, leads the financial strategy and operations specifically for the Precision AQ division. Shusko's expertise ensures the financial viability and strategic growth of this specialized unit, which contributes to the company's broader mission of supporting pharmaceutical and life-sciences clients. This involves managing financial resources to facilitate the development and commercialization of innovative solutions, integrating advanced lab sciences and informatics. The Chief Financial Officer's role is crucial for driving financial performance and supporting the unique objectives of Precision AQ. Wendy Shusko's financial leadership ensures that the division operates efficiently and effectively, contributing to the overall success of Precision Medicine Group's client services. Shusko's focus is on robust financial planning and execution within the Precision AQ framework.

Chad Clarke, the President at Precision Medicine Group, drives strategic initiatives and operational excellence across the organization. Clarke's leadership focuses on enhancing the company's capabilities in providing comprehensive development and commercialization services to pharmaceutical and life-sciences clients. This involves fostering collaboration among experts in advanced lab sciences, translational informatics, and regulatory affairs to address complex market challenges. The President's role is instrumental in guiding the company's growth trajectory and ensuring client success in a dynamic environment. Chad Clarke's strategic vision supports the company's mission to conquer product development hurdles and achieve impactful commercialization outcomes. Clarke's leadership ensures the effective implementation of the company's core strategies.

Othniel Badea, the Chief Technology Officer at Precision Medicine Group, architects the technological infrastructure and digital strategy that underpins the company's advanced services. Badea's expertise in translational informatics and data science is crucial for developing innovative solutions that help pharmaceutical and life-sciences clients overcome product development and commercialization challenges. This involves overseeing the integration of cutting-edge technologies to enhance lab sciences, regulatory affairs, and payer insights. The Chief Technology Officer's role is vital in ensuring that Precision Medicine Group remains at the forefront of technological advancement within the life sciences sector. Badea drives the development of robust data platforms and analytical tools that empower clients with actionable intelligence. Othniel Badea's leadership ensures the technological backbone supports the company's mission to deliver impactful development and commercialization services.

David Winn, the Chief Administrative Officer, Clinical Solutions at Precision Medicine Group, oversees the administrative functions critical to the success of the company's clinical solutions division. Winn's leadership ensures that operational processes are optimized to support the delivery of development and commercialization services for pharmaceutical and life-sciences clients. This involves managing resources and streamlining workflows to enhance efficiency in areas such as regulatory affairs and payer insights. The Chief Administrative Officer's role is vital in maintaining the operational integrity and effectiveness of the clinical solutions team. David Winn's focus is on establishing robust administrative frameworks that facilitate seamless project execution and client support. Winn's contributions are key to the smooth functioning of the clinical solutions operations.